243 related articles for article (PubMed ID: 12829429)
1. Regulation of SM22 alpha expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells.
Kaplan-Albuquerque N; Garat C; Van Putten V; Nemenoff RA
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1444-52. PubMed ID: 12829429
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor.
Kaplan-Albuquerque N; Garat C; Desseva C; Jones PL; Nemenoff RA
J Biol Chem; 2003 Oct; 278(41):39830-8. PubMed ID: 12882977
[TBL] [Abstract][Full Text] [Related]
3. Induction of smooth muscle alpha-actin in vascular smooth muscle cells by arginine vasopressin is mediated by c-Jun amino-terminal kinases and p38 mitogen-activated protein kinase.
Garat C; Van Putten V; Refaat ZA; Dessev C; Han SY; Nemenoff RA
J Biol Chem; 2000 Jul; 275(29):22537-43. PubMed ID: 10807920
[TBL] [Abstract][Full Text] [Related]
4. Regulation of smooth muscle alpha-actin promoter by vasopressin and platelet-derived growth factor in rat aortic vascular smooth muscle cells.
Van Putten V; Li X; Maselli J; Nemenoff RA
Circ Res; 1994 Dec; 75(6):1126-30. PubMed ID: 7955149
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes.
Dandré F; Owens GK
Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2042-51. PubMed ID: 14751865
[TBL] [Abstract][Full Text] [Related]
6. Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2.
Li X; Van Putten V; Zarinetchi F; Nicks ME; Thaler S; Heasley LE; Nemenoff RA
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):709-16. PubMed ID: 9581546
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
9. PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns.
Thomas JA; Deaton RA; Hastings NE; Shang Y; Moehle CW; Eriksson U; Topouzis S; Wamhoff BR; Blackman BR; Owens GK
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H442-52. PubMed ID: 19028801
[TBL] [Abstract][Full Text] [Related]
10. A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis.
Wamhoff BR; Hoofnagle MH; Burns A; Sinha S; McDonald OG; Owens GK
Circ Res; 2004 Nov; 95(10):981-8. PubMed ID: 15486317
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters.
Yoshida T; Gan Q; Shang Y; Owens GK
Am J Physiol Cell Physiol; 2007 Feb; 292(2):C886-95. PubMed ID: 16987998
[TBL] [Abstract][Full Text] [Related]
12. ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements.
Yu K; Zheng B; Han M; Wen JK
Cardiovasc Res; 2011 Jun; 90(3):464-74. PubMed ID: 21252119
[TBL] [Abstract][Full Text] [Related]
13. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
[TBL] [Abstract][Full Text] [Related]
14. Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro.
Yu J; Li Y; Li M; Qu Z; Ruan Q
Int J Exp Pathol; 2010 Feb; 91(1):24-33. PubMed ID: 20096071
[TBL] [Abstract][Full Text] [Related]
15. Ras/ERK signaling pathway mediates activation of the p21WAF1 gene promoter in vascular smooth muscle cells by platelet-derived growth factor.
Lee B; Moon SK
Arch Biochem Biophys; 2005 Nov; 443(1-2):113-9. PubMed ID: 16248979
[TBL] [Abstract][Full Text] [Related]
16. Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis.
Inui H; Kitami Y; Tani M; Kondo T; Inagami T
J Biol Chem; 1994 Dec; 269(48):30546-52. PubMed ID: 7982973
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide regulates smooth-muscle-specific myosin heavy chain gene expression at the transcriptional level-possible role of SRF and YY1 through CArG element.
Itoh S; Katoh Y; Konishi H; Takaya N; Kimura T; Periasamy M; Yamaguchi H
J Mol Cell Cardiol; 2001 Jan; 33(1):95-107. PubMed ID: 11133226
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr-1.
Kamimura M; Bea F; Akizawa T; Katus HA; Kreuzer J; Viedt C
Hypertension; 2004 Dec; 44(6):944-51. PubMed ID: 15492129
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor-BB-induced hypertrophy of peritubular smooth muscle cells is mediated by activation of p38 MAP-kinase and of Rho-kinase.
Romano F; Chiarenza C; Palombi F; Filippini A; Padula F; Ziparo E; De Cesaris P
J Cell Physiol; 2006 Apr; 207(1):123-31. PubMed ID: 16270352
[TBL] [Abstract][Full Text] [Related]
20. Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle alpha-actin content and abolishes the platelet-derived growth factor-BB-stimulated DNA synthesis.
Sachinidis A; Seul C; Gouni-Berthold I; Seewald S; Ko Y; Vetter H; Fingerle J; Hoppe J
Br J Pharmacol; 2000 Aug; 130(7):1561-70. PubMed ID: 10928958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
